4
Changes in Ownership
Kiniksa Pharmaceuticals International, plc Filed Acc 0001464583-26-000006
CHIEF ACCOUNTING OFFICER sold 6,625 shares at $46.69 ($309,321)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Megna Michael R · CHIEF ACCOUNTING OFFICER
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-04-09 | Sale : show line 1 in the form 10b5-1 | −6,625 | $46.69 | $309,321 | 27,418 | D |
| Open-market sales · 6,625 sh · avg $46.69 · $309,321 | ||||||
Loading xslF345X06/form4-04132026_080442.xml…